We moved to a new platform offering additional features for our attendees and presenters to connect. If you have registered/signed up at VirtualInvestorConferences.com prior to March 3, 2022, you will need to sign up again. The good news is that once you sign up for the new platform, you will be able to seamlessly visit all of our recent and upcoming events!
Thursday, March 10th Agenda
VolitionRX Limited
NYSE American: VNRX
Industry: Epigenetics – Cancer Screening/Veterinary
Scott Powell, Head of Investor Relations & U.S. Chief Financial Officer
nDatalyze Corp.
OTCQB: NDATF | CSE: NDAT
Industry: Medtech – Mental Health
James Durward, President & CEO
Khiron Life Sciences Corp.
OTCQX: KHRNF | TSX-V: KHRN
Industry: Medical Cannabis and Health Clinics
Alvaro Torres, CEO
Universal Ibogaine
OTCQB: IBOGF | TSX-V: IBO
Industry: Biopharma – Addiction Treatment
Dugan Selkirk, IR PR Manager
Nick Karos, CEO
Alpha Cognition, Inc.
OTCQB: ACOGF | TSX-V: ACOG
Industry: Biopharma – Neurodegenerative and ALS
Michael McFadden, CEO
Resverlogix Corp.
Pink: RVXCF | TSX: RVX
Industry: Biotech – Epigenetic
Donald McCaffrey, President and CEO
Satellos Bioscience Inc.
Pink: MSCLF | TSX-V: MSCL
Industry: Biotechnology - regenerative medicine
Frank Gleeson, Founder & CEO
Stealth BioTherapeutics Inc.
Nasdaq: MITO
Industry: Biotech – Ophthalmology/Neurology
Reenie McCarthy, CEO
Appili Therapeutics Inc.
OTCQX: APLIF | TSX: APLI
Industry: Biopharma – Infectious Diseases
Stéphane Paquette, PhD, Vice President, Corporate Development
RetinalGeniX Technologies Inc.
OTCQB: RTGN
Industry: Medtech – Retinal Screening
Jerry Katzman, MD, Chairman, President & CEO